Nihon Kohden Corporation (TYO: 6849)
Japan
· Delayed Price · Currency is JPY 2,094.50
+41.50 (2.02%)
Jan 20, 2025, 3:30 PM JST
Nihon Kohden Revenue
Nihon Kohden had revenue of 56.56B JPY in the quarter ending September 30, 2024, with 3.19% growth. This brings the company's revenue in the last twelve months to 221.23B, up 2.52% year-over-year. In the fiscal year ending March 31, 2024, Nihon Kohden had annual revenue of 221.99B with 7.45% growth.
Revenue (ttm)
221.23B
Revenue Growth
+2.52%
P/S Ratio
1.59
Revenue / Employee
37.55M
Employees
5,891
Market Cap
345.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 221.99B | 15.38B | 7.45% |
| Mar 31, 2023 | 206.60B | 1.47B | 0.72% |
| Mar 31, 2022 | 205.13B | 5.40B | 2.70% |
| Mar 31, 2021 | 199.73B | 14.72B | 7.96% |
| Mar 31, 2020 | 185.01B | 6.21B | 3.47% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Terumo | 986.67B |
| Otsuka Holdings | 2,269.56B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |